IncellDx, Kindstar Reach Deal to Bring HPV/Cervical Cancer Test to China – GenomeWeb

IncellDx, Kindstar Reach Deal to Bring HPV/Cervical Cancer Test to China
GenomeWeb
It measures the potential oncogenic activity of HPV in infected cervical cells, detecting and quantifying the expression of viral oncogenes that are responsible for triggering progression to cervical cancer, the Menlo Park, Calif.-based firm said
IncellDx Signs Deal With Kindstar Global to Offer Novel HPV Technology in GlobeNewswire (press release)

all 2 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *